Identifying and addressing unmet clinical needs in Ph-neg classical myeloproliferative neoplasms: a consensus-based SIE, SIES, GITMO position paper.

Identifying and addressing unmet clinical needs in Ph-neg classical myeloproliferative neoplasms: a consensus-based SIE, SIES, GITMO position paper.

Item
http://www.wikidata.org/entity/Q38174710
Critical appraisal of the role of ruxolitinib in myeloproliferative neoplasm-associated myelofibrosisThrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: the role of the WHO histological diagnosisCurrent and future treatment options for polycythemia vera.Thrombotic risk assessment in 185 WHO-defined essential thrombocythemia patients: single center experience.Clinical Features of 294 Turkish Patients with Chronic Myeloproliferative Neoplasms.Current opinion and consensus statement regarding the diagnosis, prognosis, and treatment of patients with essential thrombocythemia: a survey of the Spanish Group of Ph-negative Myeloproliferative Neoplasms (GEMFIN) using the Delphi method.Is it time to revisit contraindications to organ donation from donors with a JAK-2 mutation? Safe use of a liver allograft from a donor with essential thrombocythaemia.JAK2(V617F) allele burden ⩾50% is associated with response to ruxolitinib in persons with MPN-associated myelofibrosis and splenomegaly requiring therapy.Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms.Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria.The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet.WHO-histological criteria for myeloproliferative neoplasms: reproducibility, diagnostic accuracy and correlation with gene mutations and clinical outcomes.Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018.
P2860

Identifying and addressing unmet clinical needs in Ph-neg classical myeloproliferative neoplasms: a consensus-based SIE, SIES, GITMO position paper.

Item
http://www.wikidata.org/entity/Q38174710
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Identifying and addressing unm ...... E, SIES, GITMO position paper.
@en
type
label
Identifying and addressing unm ...... E, SIES, GITMO position paper.
@en
prefLabel
Identifying and addressing unm ...... E, SIES, GITMO position paper.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Identifying and addressing unm ...... E, SIES, GITMO position paper.
@en
P2093
P304
P31
P356
10.1016/J.LEUKRES.2013.09.008
P433
P478
P50
P577
P698